| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2006 | CN1762370A Polyene phosphatidyl choline lyophilized powdered injection |
| 04/26/2006 | CN1762369A Vertical transmitted antidysenteric |
| 04/26/2006 | CN1762368A Usage of ocotillol in preparation of medicine for treating or preventing senile dementia |
| 04/26/2006 | CN1762367A Ursodeoxycholic acid pills formula and its preparation method |
| 04/26/2006 | CN1762366A Levonogestrel transdermal control-releasing transfer system and its multifunctional patch |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762364A Formula of blood brain barrier-passing quickly highly-efficient anti-cancer medicine and its preparation process |
| 04/26/2006 | CN1762363A Arteannuin pills formula and its preparation process |
| 04/26/2006 | CN1762362A Medicinal composition with red sage root component for treating cardiovascular and cerebrovascular disease and its application |
| 04/26/2006 | CN1762361A Pharmaceutical composition containing amiodipine besylate and rosuvastatin calcium, and its preparation method |
| 04/26/2006 | CN1762360A Compound cetirizine hydrochloride gel |
| 04/26/2006 | CN1762359A Lindera root alkaloid, its preparation method and application in medicine preparation |
| 04/26/2006 | CN1762358A Moxifloxacin capsule and its preparation method |
| 04/26/2006 | CN1762357A Oral medicinal formulation of moxifloxacin and its preparation method |
| 04/26/2006 | CN1762356A Pharmaceutical composition and its application in preparation of medicine for treating type II diabetes |
| 04/26/2006 | CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 04/26/2006 | CN1762354A Stable pharmaceutical composition containing calcium blocker |
| 04/26/2006 | CN1762353A Pharmaceutical composition containing amiodipine besylate and nisvastatin calcium and its preparation method |
| 04/26/2006 | CN1762352A Phentolamine mesylate pills and its preparation method |
| 04/26/2006 | CN1762351A Tinizadole dental plaster for treating buccal inflammation |
| 04/26/2006 | CN1762350A Bendazac lysine eye drops with reduced irritability, its preparation method and application |
| 04/26/2006 | CN1762349A Externally applied ointment of ketorolac tromethamine and its preparation method |
| 04/26/2006 | CN1762348A Formula of bergeninum pills and its preparation method |
| 04/26/2006 | CN1762347A Andrographolide preparation and its production method |
| 04/26/2006 | CN1762346A Application of tripholide in preparation of anti-oophoroma medicine |
| 04/26/2006 | CN1762345A Silybinin injection and its preparation method |
| 04/26/2006 | CN1762344A Silybinin lyophilized formulation and its preparation method |
| 04/26/2006 | CN1762343A EGCG-zinc complex solid dispersion, its preparation method and application |
| 04/26/2006 | CN1762342A Safflor yellow A-containing pharmaceutical composition, its preparation method and usage |
| 04/26/2006 | CN1762341A Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof |
| 04/26/2006 | CN1762340A Composite tramadol hydrochloride formulation and preparation process thereof |
| 04/26/2006 | CN1762339A Contraceptive, sterilizing, virus-inhibiting medicine |
| 04/26/2006 | CN1762338A Treatment method of conduct disorder |
| 04/26/2006 | CN1762337A Eye wrinkle-removing film patch |
| 04/26/2006 | CN1253464C Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/26/2006 | CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/26/2006 | CN1253458C Process for preparing substance GM-95 |
| 04/26/2006 | CN1253455C 2-3-methylen-dioxy dibenzo [a,g] quinolizine onium hydrochloride and its uses in treatment of diabete |
| 04/26/2006 | CN1253454C Beta-carboline and thio-analogues subsitituted by amino-acid radical/acyl, preparing method and application thereof |
| 04/26/2006 | CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253440C New iso quinoline compound with HIV-1 resisting activity |
| 04/26/2006 | CN1253437C Medicinal compound for curing disease of gastrointestinal tract, preparation method and relevant medication |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253209C Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof |
| 04/26/2006 | CN1253173C Inclusion active substance improved vitamin U belladonna and aluminium capsule II |
| 04/26/2006 | CN1253172C Anti-allergic agents, drugs, foods, or cosmetics containing them and process for producing the same |
| 04/26/2006 | CN1253169C Chinese medicine composition for treating apoplexy and its preparation method |
| 04/26/2006 | CN1253159C Health product of compound propolis and preparing method |
| 04/26/2006 | CN1253158C Luminescent bio-element and preparation process thereof |
| 04/26/2006 | CN1253157C Acne-removing cream |
| 04/26/2006 | CN1253156C Orally disintegrating tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 04/26/2006 | CN1253155C Whelk-treating medicine composition and its preparation method |
| 04/26/2006 | CN1253154C Method for preparing cefathiamidine freeze-dried sterile raw material medicine |
| 04/26/2006 | CN1253153C Use of trivalency chromium in preparation of drug against allergic rhinitis |
| 04/26/2006 | CN1253152C Single particle nano-garlicin micro-capsule, and its preparation method |
| 04/26/2006 | CN1253151C Use of MGLUR 5 antagonists for treatment of pruritic conditions |
| 04/26/2006 | CN1253150C Xa factor inhibitor on its own and/or combined with platelet anti-aggegating agent |
| 04/26/2006 | CN1253149C Percutaneously absorbable patches |
| 04/26/2006 | CN1253145C Blood sugar reducing skin-care cream specially for curing diabetes and its producing method |
| 04/26/2006 | CN1253099C Taste modifiers comprising chlorogenic acid |
| 04/25/2006 | USRE39078 Recombinant adenoviruses for gene therapy in cancers |
| 04/25/2006 | US7034692 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 04/25/2006 | US7034201 Developmental animal model of temporal lobe epilepsy |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7034162 Refluxing aqueous solution of sumatriptan, or salt thereof, in alcoholic solvents |
| 04/25/2006 | US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders |
| 04/25/2006 | US7034159 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034151 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034127 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034060 Mixture of fatty alcohols; dietetics; antidiabetic agents ; anticholesterol agents; antiischemic agents; thrombosis |
| 04/25/2006 | US7034059 Reducing production of PGE2; treating autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, and cancer |
| 04/25/2006 | US7034058 Anti-tumor pharmaceutical composition comprising N-vanillyl fatty acid amide |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034055 2-aminoindane analogs |
| 04/25/2006 | US7034054 Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols |
| 04/25/2006 | US7034053 beta-adrenoceptor agonist for the prevention or treatment of obesity; Suitable compounds of formula (I) of the invention include:2-(3-{2R-[2-(3-Chlorophenyl)-2R-hydroxyl-ethylamino]propylamino}phenyl)furan-3-carboxylic acid |
| 04/25/2006 | US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome |
| 04/25/2006 | US7034051 Fused bicyclic carboxamide derivatives and methods of their use |
| 04/25/2006 | US7034050 Animal growth regulators |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034048 Gastrin and cholecystokinin receptor ligands (III) |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034044 NMDA (N-methyl-D- aspartate)-receptor subtype blockers and are used in the treatment or prevention of CNS disorders i.e. Alzheimer's, Parkinson's, etc. |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034041 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine |
| 04/25/2006 | US7034040 Fluorinated heterocyclic compounds and methods of synthesis |